National Cancer Institute Annual Report, Vol. 2
Title | National Cancer Institute Annual Report, Vol. 2 PDF eBook |
Author | U. S. National Cancer Institute |
Publisher | Forgotten Books |
Pages | 1140 |
Release | 2018-03-30 |
Genre | Medical |
ISBN | 9780365703426 |
Excerpt from National Cancer Institute Annual Report, Vol. 2: October 1, 1986 Through September 30, 1987 About the Publisher Forgotten Books publishes hundreds of thousands of rare and classic books. Find more at www.forgottenbooks.com This book is a reproduction of an important historical work. Forgotten Books uses state-of-the-art technology to digitally reconstruct the work, preserving the original format whilst repairing imperfections present in the aged copy. In rare cases, an imperfection in the original, such as a blemish or missing page, may be replicated in our edition. We do, however, repair the vast majority of imperfections successfully; any imperfections that remain are intentionally left to preserve the state of such historical works.
National Cancer Institute Annual Report, Vol. 2
Title | National Cancer Institute Annual Report, Vol. 2 PDF eBook |
Author | National Cancer Institute |
Publisher | Forgotten Books |
Pages | 608 |
Release | 2018-03-03 |
Genre | |
ISBN | 9780332893167 |
Excerpt from National Cancer Institute Annual Report, Vol. 2: October 1, 1989, Through September 30, 1990 The Investigational Drug Branch (108) is responsible for sponsoring trials of new investigational drugs and of evaluating them for efficacy and toxicity. It does this by: I) Coordinating and monitoring the trials of new agents developed by the oct; 2) Planning with members of the Clinical Investigations Branch (see below overall strategies for new agent studies in specific tumor types; 3) Regulating the distribution of investigational new drugs for which oct is the sponsor; 4) Maintain close contact and ongoing dialogue with the pharmaceutical industry in an attempt to ensure that new agent development proceeds in a coordinated way. The Clinical Investigations Branch (cib) is responsible for development and implementation of disease-oriented treatment strategies across the spectrum of human malignancies. In doing so, it provides management and oversight of the clinical cooperative group program. It manages the oncology portfolios of R01 and P01 grants. The Regulatory Affairs Branch (rab) monitors the conduct of clinical trials performed in the nci-supported clinical trials network. It also assures that clinical investigators using experimental agents are in compliance with federal regulations regarding the use of such agents. At the start of the clinical testing of each investigational agent, rab obtains Investigational New Drug (nda) exemption authorization from the Food and Drug Administration (fda) and maintains close communication with fda in all matters relating to experimental drug studies. About the Publisher Forgotten Books publishes hundreds of thousands of rare and classic books. Find more at www.forgottenbooks.com This book is a reproduction of an important historical work. Forgotten Books uses state-of-the-art technology to digitally reconstruct the work, preserving the original format whilst repairing imperfections present in the aged copy. In rare cases, an imperfection in the original, such as a blemish or missing page, may be replicated in our edition. We do, however, repair the vast majority of imperfections successfully; any imperfections that remain are intentionally left to preserve the state of such historical works.
Annual Report
Title | Annual Report PDF eBook |
Author | National Cancer Institute (U.S.). Division of Cancer Biology, Diagnosis, and Centers |
Publisher | |
Pages | 102 |
Release | 1995 |
Genre | |
ISBN |
Annual Report
Title | Annual Report PDF eBook |
Author | National Cancer Institute (U S ) |
Publisher | Arkose Press |
Pages | 592 |
Release | 2015-11-02 |
Genre | |
ISBN | 9781345811179 |
This work has been selected by scholars as being culturally important, and is part of the knowledge base of civilization as we know it. This work was reproduced from the original artifact, and remains as true to the original work as possible. Therefore, you will see the original copyright references, library stamps (as most of these works have been housed in our most important libraries around the world), and other notations in the work. This work is in the public domain in the United States of America, and possibly other nations. Within the United States, you may freely copy and distribute this work, as no entity (individual or corporate) has a copyright on the body of the work. As a reproduction of a historical artifact, this work may contain missing or blurred pages, poor pictures, errant marks, etc. Scholars believe, and we concur, that this work is important enough to be preserved, reproduced, and made generally available to the public. We appreciate your support of the preservation process, and thank you for being an important part of keeping this knowledge alive and relevant.
Annual Report - National Cancer Institute, Division of Cancer Research Resources and Centers
Title | Annual Report - National Cancer Institute, Division of Cancer Research Resources and Centers PDF eBook |
Author | National Cancer Institute (U.S.). Division of Cancer Research Resources and Centers |
Publisher | |
Pages | 92 |
Release | |
Genre | |
ISBN |
Annual Report
Title | Annual Report PDF eBook |
Author | National Cancer Institute (U.S.) |
Publisher | |
Pages | 84 |
Release | 1979 |
Genre | Cancer |
ISBN |
Annual Report - National Cancer Institute
Title | Annual Report - National Cancer Institute PDF eBook |
Author | National Cancer Institute (U.S.) |
Publisher | |
Pages | 826 |
Release | 1976 |
Genre | Cancer |
ISBN |